Janus kinase 1 inhibitor abrocitinib for isolated nail lichen planus: a case report and literature review

Janus kinase 1 inhibitor abrocitinib for isolated nail lichen planus: a case report and literature review

Aim This study aims to evaluate the efficacy and safety of the Janus kinase 1 (JAK1) inhibitor abrocitinib for treating nail lichen planus (NLP) and to review available case reports documented in English.Methods We reported the first case of a patient with isolated NLP treated with the selective JAK...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan He, Yi Yang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Dermatological Treatment
Subjects:
Lichen planus
nail disorder
inflammation disease
JAK inhibitor
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2024.2434094
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items